Dermata Therapeutics Inc Share Price

NASDAQ: DRMA

Small Cap

$5.91

+0.48

(+8.75%)

as on September 17, 2025 at 1:29 am IST

$₹

Dermata Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$5.54
Day's Price Range
$6.21
$5.91
6.26%
Downside
5.08%
Upside
52 Week's Low
52 Week's High
$5.04
52-Week Price Range
$23.8
$5.91
14.70%
Downside
302.71%
Upside

Dermata Therapeutics Inc share price movements today

Previous Close: $5.43
Open: $5.62
Volume: 776.5K
Day's Low - High: $5.54 - $6.21
52 Week Low - High: $5.04 - $23.8

Dermata Therapeutics Inc Historical Returns

1 Month Return: -1.25 %
3 Month Return: -16.55 %
1 Year Return: -71.33 %
3 Year Return: -99.6 %
5 Year Return: 0 %

Dermata Therapeutics Inc Stock Fundamentals & Key Indicators

Check Dermata Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.7M

EPS (TTM)

-7.76

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.26

Industry PE ratio

P/B Ratio

0.2591

PEG Ratio

EBITDA

-7.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-231.27%

Dermata Therapeutics Inc Stock Valuation

Track how Dermata Therapeutics Inc P/E has moved over time to understand its valuation trends.

Dermata Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Industry (0.00x)

September 17, 2025

Today (0.26x)

September 17, 2025

Highest (-0.40x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 0.26x

Dermata Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dermata Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Dermata Therapeutics Inc	BUY	$3.7M	NA	0.26	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Dermata Therapeutics Inc Stock including INR - Dollar returns

The Dermata Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Dermata Therapeutics Inc investment value today

Current value as on today

₹33,557

Returns

₹66,443

(-66.44%)

Returns from Dermata Therapeutics Inc Stock

₹71,311 (-71.31%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Dermata Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Dermata Therapeutics Inc. Average target price of $10

Dermata Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Dermata Therapeutics Inc.

What analysts predicted

40.9%UPSIDE

Target Price

$10

Current Price

$5.91

Analyzed by

7 Analysts

Target

$10.00

Dermata Therapeutics Inc target price $10, a slight upside of 40.9% compared to current price of $5.91. According to 7 analysts rating.

Dermata Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Dermata Therapeutics Inc Stock has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-64% versus previous 30 day period

Dermata Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-2	-1	-1	-2	-3	-2	-3	-3	-2	-1
EBITDA	-2	-1	-1	-2	-3	-2	-3	-3	-2	-1
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-1	-1	-2	-3	-2	-3	-3	-2	-1
Income Tax Expense	0	0	0	0	-3	-2	-	3	-	-
Net Income	-2	-1	-1	-2	-3	-2	-3	-3	-2	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Dermata Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	-	-	-	-
Operating Income	-4	-3	-7	-9	-8	-12
EBITDA	-4	-3	-7	-9	0	-12
Interest Expense	0	0	0	0	-	-
Depreciation	0	0	-	-	-	-
Income Before Tax	-4	-3	-7	-9	-7	-12
Income Tax Expense	0	0	0	0	0	-
Net Income	-4	-3	-7	-9	-7	-12
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Dermata Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-1	-1	-2	-3	-2	-3	-3	-2	-1
Operating Cash Flow	-1	-1	-1	-2	-2	-3	-2	-1	-2
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	1	0	1	-	2	4	0	8	0
Change in Cash	0	-1	0	-2	0	1	-2	6	-3

Dermata Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-3	-7	-9	-7	-12
Operating Cash Flow	-4	-5	-8	-6	-11
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	2	15	4	7	6
Change in Cash	-1	10	-4	1	-4

Global Institutional Holdings in Dermata Therapeutics Inc

Funds	Holdings
Armistice Capital, LLC	6.44%
UBS Group AG	1.1%
Geode Capital Management, LLC	0.32%
JONES FINANCIAL COMPANIES LLLP	0.19%
Wells Fargo & Co	0.03%

See all

Insights on Dermata Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 216.1%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 139.4%
NEGATIVE IMPACT
Price Dip
In the last 6 months, DRMA stock has moved down by -49.5%

About Dermata Therapeutics Inc

dermata therapeutics, llc is a research company based out of 12340 el camino real, san diego, california, united states.

Organisation	Dermata Therapeutics Inc
Headquarters	3525 Del Mar Heights Rd., San Diego, CA, United States, 92130
CEO	Mr. Gerald T. Proehl
E-voting on shares	Click here to vote

Key Management of Dermata Therapeutics Inc

Name	Title
Mr. Sean Proehl	Associate General Counsel
Dr. Maria Bedoya Toro Munera M.B.A., Ph.D.	Senior Vice President of Regulatory Affairs & Quality Assurance
Mr. Gerald T. Proehl	Founder, President, CEO & Chairman
Mr. David F. Hale	Co-Founder & Lead Independent Director
Ms. Kyri K. Van Hoose CPA, M.B.A.	Senior VP & CFO
Dr. Christopher J. Nardo M.P.H., Ph.D.	Senior VP & Chief Development Officer

FAQs

What is Dermata Therapeutics Inc share price today?

Dermata Therapeutics Inc share price today is $5.91 as on September 17, 2025 at 1:29 am IST at the close of the market. Dermata Therapeutics Inc share today touched a day high of $6.21 and a low of $5.54.

What is the 52 week high and 52 week low for Dermata Therapeutics Inc share?

Dermata Therapeutics Inc share touched a 52 week high of $23.8 on September 18, 2024 and a 52 week low of $5.04 on September 9, 2025. Dermata Therapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $5.91,which is 75.17% down from its 52 week high and 17.23% up from its 52 week low.

What is Dermata Therapeutics Inc's market capitalisation today?

Dermata Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Dermata Therapeutics Inc Stock (DRMA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Dermata Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dermata Therapeutics Inc Shares that will get you 0.2538 shares as per Dermata Therapeutics Inc share price of $5.91 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Dermata Therapeutics Inc Stock (DRMA) from India?

Indian investors can start investing in Dermata Therapeutics Inc (DRMA) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 3:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Dermata Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 3:44 pm IST). Based on Dermata Therapeutics Inc share’s latest price of $5.91 as on September 17, 2025 at 1:29 am IST, you will get 1.6920 shares of Dermata Therapeutics Inc. Learn more about fractional shares .